Legal Opinion
Apotex Inc. v. U.S. Food & Drug Administration
District Court, District of Columbia
Decided September 17, 2007No. Civil Action 07-1194(RMU)PublishedCited by 7 opinions
1Opinion of the Court
MEMORANDUM OPINION
Denying the Plaintiff’s Motion for Injunctive Relief
URBINA, District Judge.
1. INTRODUCTION
The plaintiff, Apotex, Inc., has marketed a generic version of the drug Prilosec for over three years pursuant to the approval of defendant 1 U.S. Food and Drug Administration (“FDA”). On June 28, 2007, subsequent to a court order concluding that the plaintiffs actions violated two of intervenor-defendant AstraZeneca’s 2 (“Astra”) patents for brand-name Prilosec, the FDA revoked the plaintiffs approval to continue marketing its generic drug. The revocation of the plaintiffs final…
2Cases cited34 opinions
- Chevron U. S. A. Inc. v. Natural Resources Defense Council, Inc.Supreme Court of the United States · 1984
- Motor Vehicle Mfrs. Assn. of United States, Inc. v. State Farm Mut. Automobile Ins. Co.Supreme Court of the United States · 1983
- Citizens to Preserve Overton Park, Inc. v. VolpeSupreme Court of the United States · 1971
- Califano v. SandersSupreme Court of the United States · 1977
- Bowman Transportation, Inc. v. Arkansas-Best Freight System, Inc.Supreme Court of the United States · 1975
29 more not listed; retrieve them via the Exa API.
3Cited by7 opinions
- Astrazeneca Ab v. Apotex Corp.Court of Appeals for the Federal Circuit · 2015
- Natural Resources Defense Council v. United States Food & Drug AdministrationDistrict Court, S.D. New York · 2012
- AstraZeneca AB v. Apotex Corp.District Court, S.D. New York · 2013
- CAREER COLLEGE ASS'N v. DuncanDistrict Court, District of Columbia · 2011
- Career College Association v. DuncanDistrict Court, District of Columbia · 2011
2 more not listed; retrieve them via the Exa API.